Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Gainers • Chimerix, Inc. (NASDAQ:CMRX) shares increased by 38.41% to $2.09 during Wednesday's pre-market session. • Accuray, Inc. (NASDAQ:ARAY) shares increased by...
Cytosorbents’ flagship product, CytoSorb can help interrupt the cytokine storm seen in COVID-19 patients with acute respiratory distress syndrome. Cytokine stor
Bryony Baynes, 58, head teacher at Kempsey Primary School in Worcester, said social distancing is "pretty much impossible" with young children. She said the thoughts of re-opening early was "giving me
Fly Intel: Pre-market Movers ATHX MRKR MUR BCRX BA TXN ACB NXPI CAT
Gainers • Biocept, Inc. (NASDAQ:BIOC) stock moved upwards by 55.72% to $0.56 during Monday's pre-market session. • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock...
The number of U.S. cases of the coronavirus that causes COVID-19 rose above 500,000 on Friday, while the death toll climbed by more than 2,000 to surpass...
The Food and Drug Administration (FDA) on Friday issued emergency use authorizations to blood purification devices manufactured by Terumo Corp. undefined and...
The Food and Drug Administration (FDA) on Friday issued emergency use authorizations to blood purification devices manufactured by Terumo Corp. and Marker Therapeutics AG in response to the COVID-19
Jagdeep Birdi at Colville Primary School in Portobello is abiding by government guidance
Headteachers question official policy of staying open as staff and students stay at home
The London Economic | Coronavirus UK - Teachers demand explanation from Johnson on decision not to shut schools | News
Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological ma
Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
The London Economic | The new Reception Baseline Assessment will be rolled out across all primary schools from September.| News
Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE